APOA5 and metabolic syndrome: As demonstrated in Table 2 for the APOA5 rs662799 SNP, there was an indication of an increased MetS risk among the MetS and non-MetS subjects after adjustment of covariates such as age and sex for the dominant model (odds ratio (OR) = 1.40; 95% confidence interval (CI) = 1.27-1.56; P = 1.2 x10-10).